Get started
Insulet CorporationInsulet CorporationInsulet Corporation

Insulet Corporation

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsForecastSeasonalsBondsETFs

GOV chart


Full chart

GOV upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪19.06 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
95.79
Basic EPS (TTM)
2.86 EUR
Net income (FY)
‪404.07 M‬ EUR
Revenue (FY)
‪2.00 B‬ EUR
Shares float
‪70.09 M‬
Beta (1Y)
0.75

Employees


Employees (FY)
‪3.9 K‬
Change (1Y)
+900 +30.00%
Revenue / Employee (1Y)
‪513.11 K‬ EUR
Net income / Employee (1Y)
‪103.61 K‬ EUR

About Insulet Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
Ashley A. McEvoy
Website
insulet.com
Headquarters
Acton
Founded
2000
ISIN
US45784P1012
FIGI
BBG00QK36X40
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Check out other big names from the same industry as GOV.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

GOV news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

GOV highest yielding bonds


PODD6033743
Insulet Corporation 6.5% 01-APR-2033
Yield to maturity
5.87%
Maturity date
Apr 1, 2033

See all GOV bonds 

ETFs with GOV exposure


360200
KIM ACE S&P500 ETF
Weight
100.00%
Market value
‪1.72 B‬
USD
VTI
Vanguard Total Stock Market ETF
Weight
0.04%
Market value
‪752.56 M‬
USD
VOO
Vanguard S&P 500 ETF
Weight
0.04%
Market value
‪597.58 M‬
USD
VB
Vanguard Small-Cap ETF
Weight
0.18%
Market value
‪290.89 M‬
USD
IVV
iShares Core S&P 500 ETF
Weight
0.04%
Market value
‪270.98 M‬
USD
VO
Vanguard Mid-Cap ETF
Weight
0.13%
Market value
‪266.26 M‬
USD
SPY
SPDR S&P 500 ETF
Weight
0.04%
Market value
‪265.06 M‬
USD
SPY
SPDR S&P 500 ETF Trust
Weight
0.04%
Market value
‪265.06 M‬
USD
VUG
Vanguard Growth ETF
Weight
0.05%
Market value
‪174.42 M‬
USD
VBK
Vanguard Small-Cap Growth ETF
Weight
0.41%
Market value
‪162.44 M‬
USD
XLV
Health Care Select Sector SPDR Fund
Weight
0.43%
Market value
‪152.56 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of GOV is 275.50 EUR — it hasn't changed in the past 24 hours. Watch Insulet Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Insulet Corporation stocks are traded under the ticker GOV.
GOV stock has risen by 3.87% compared to the previous week, the month change is a −5.01% fall, over the last year Insulet Corporation has showed a 28.26% increase.
We've gathered analysts' opinions on Insulet Corporation future price: according to them, GOV price has a max estimate of 358.70 EUR and a min estimate of 259.30 EUR. Watch GOV chart and read a more detailed Insulet Corporation stock forecast: see what analysts think of Insulet Corporation and suggest that you do with its stocks.
GOV reached its all-time high on Nov 7, 2022 with the price of 314.00 EUR, and its all-time low was 115.00 EUR and was reached on Mar 18, 2020. View more price dynamics on GOV chart.
See other stocks reaching their highest and lowest prices.
GOV stock is 3.08% volatile and has beta coefficient of 0.75. Track Insulet Corporation stock price on the chart and check out the list of the most volatile stocks — is Insulet Corporation there?
Today Insulet Corporation has the market capitalization of ‪19.14 B‬, it has increased by 1.20% over the last week.
Yes, you can track Insulet Corporation financials in yearly and quarterly reports right on TradingView.
Insulet Corporation is going to release the next earnings report on Nov 6, 2025. Keep track of upcoming events with our Earnings Calendar.
GOV earnings for the last quarter are 0.99 EUR per share, whereas the estimation was 0.78 EUR resulting in a 27.20% surprise. The estimated earnings for the next quarter are 0.97 EUR per share. See more details about Insulet Corporation earnings.
Insulet Corporation revenue for the last quarter amounts to ‪551.02 M‬ EUR, despite the estimated figure of ‪521.40 M‬ EUR. In the next quarter, revenue is expected to reach ‪577.86 M‬ EUR.
GOV net income for the last quarter is ‪19.10 M‬ EUR, while the quarter before that showed ‪32.72 M‬ EUR of net income which accounts for −41.63% change. Track more Insulet Corporation financial stats to get the full picture.
No, GOV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 14, 2025, the company has ‪3.9 K‬ employees. See our rating of the largest employees — is Insulet Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Insulet Corporation EBITDA is ‪432.35 M‬ EUR, and current EBITDA margin is 18.81%. See more stats in Insulet Corporation financial statements.
Like other stocks, GOV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Insulet Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Insulet Corporation technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Insulet Corporation stock shows the buy signal. See more of Insulet Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.